Melanoma Research Alliance Statement on FDA Approval of Hepzato Kit for Patients with Uveal Melanoma with Liver Metastases


WASHINGTON, Aug. 15, 2023 /PRNewswire/ — The Melanoma Research Alliance (MRA) released the following statements from MRA Chief Science Officer Joan Levy, PhD and MRA Chief Executive Officer Marc Hurlbert, PhD on the Food & Drug Administration approval of Hepzato Kit for patients with…

Leave a Reply